These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29512083)

  • 41. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.
    Kreisl WC; Lyoo CH; Liow JS; Snow J; Page E; Jenko KJ; Morse CL; Zoghbi SS; Pike VW; Turner RS; Innis RB
    Neurobiol Aging; 2017 Mar; 51():132-140. PubMed ID: 28068564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of overnight smoking abstinence on a marker for microglial activation: a [
    Brody AL; Gehlbach D; Garcia LY; Enoki R; Hoh C; Vera D; Kotta KK; London ED; Okita K; Nurmi EL; Seaman LC; Mandelkern MA
    Psychopharmacology (Berl); 2018 Dec; 235(12):3525-3534. PubMed ID: 30343364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
    Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
    Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.
    Owen DR; Howell OW; Tang SP; Wells LA; Bennacef I; Bergstrom M; Gunn RN; Rabiner EA; Wilkins MR; Reynolds R; Matthews PM; Parker CA
    J Cereb Blood Flow Metab; 2010 Sep; 30(9):1608-18. PubMed ID: 20424634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation.
    Kreisl WC; Jenko KJ; Hines CS; Lyoo CH; Corona W; Morse CL; Zoghbi SS; Hyde T; Kleinman JE; Pike VW; McMahon FJ; Innis RB;
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):53-8. PubMed ID: 22968319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28.
    Lanfranca MP; Lazarus J; Shao X; Nathan H; Di Magliano MP; Zou W; Piert M; Frankel TL
    J Surg Res; 2018 Dec; 232():570-577. PubMed ID: 30463776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [
    Selvaraj S; Bloomfield PS; Cao B; Veronese M; Turkheimer F; Howes OD
    Schizophr Res; 2018 May; 195():206-214. PubMed ID: 28893493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions.
    Fairley LH; Lai KO; Grimm A; Eckert A; Barron AM
    Biochimie; 2024 Sep; 224():120-131. PubMed ID: 38971458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depiction of microglial activation in aging and dementia: Positron emission tomography with [
    Yokokura M; Terada T; Bunai T; Nakaizumi K; Takebayashi K; Iwata Y; Yoshikawa E; Futatsubashi M; Suzuki K; Mori N; Ouchi Y
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):877-889. PubMed ID: 27117856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice.
    Focke C; Blume T; Zott B; Shi Y; Deussing M; Peters F; Schmidt C; Kleinberger G; Lindner S; Gildehaus FJ; Beyer L; von Ungern-Sternberg B; Bartenstein P; Ozmen L; Baumann K; Dorostkar MM; Haass C; Adelsberger H; Herms J; Rominger A; Brendel M
    J Nucl Med; 2019 Apr; 60(4):548-554. PubMed ID: 30262517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microglial Activation and Connectivity in Alzheimer Disease and Aging.
    Rauchmann BS; Brendel M; Franzmeier N; Trappmann L; Zaganjori M; Ersoezlue E; Morenas-Rodriguez E; Guersel S; Burow L; Kurz C; Haeckert J; Tatò M; Utecht J; Papazov B; Pogarell O; Janowitz D; Buerger K; Ewers M; Palleis C; Weidinger E; Biechele G; Schuster S; Finze A; Eckenweber F; Rupprecht R; Rominger A; Goldhardt O; Grimmer T; Keeser D; Stoecklein S; Dietrich O; Bartenstein P; Levin J; Höglinger G; Perneczky R
    Ann Neurol; 2022 Nov; 92(5):768-781. PubMed ID: 36053756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.
    Datta G; Violante IR; Scott G; Zimmerman K; Santos-Ribeiro A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Matthews PM
    Mult Scler; 2017 Oct; 23(11):1469-1478. PubMed ID: 27903933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.
    Xu J; Sun J; Perrin RJ; Mach RH; Bales KR; Morris JC; Benzinger TLS; Holtzman DM
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1423-1434. PubMed ID: 31402620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App
    Biechele G; Wind K; Blume T; Sacher C; Beyer L; Eckenweber F; Franzmeier N; Ewers M; Zott B; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Tahirovic S; Willem M; Bartenstein P; Cumming P; Rominger A; Herms J; Brendel M
    Neuroimage; 2021 Apr; 230():117707. PubMed ID: 33385560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy and reliability of [
    Plavén-Sigray P; Schain M; Zanderigo F; ; Rabiner EA; Gunn RN; Ogden RT; Cervenka S
    Neuroimage; 2019 Mar; 188():102-110. PubMed ID: 30500425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.
    Janssen B; Mach RH
    Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
    Yang Z; Banks SJ; Ritter AR; Cummings JL; Sreenivasan K; Kinney JW; Caldwell JK; Wong CG; Miller JB; Cordes D
    J Alzheimers Dis; 2023; 96(4):1505-1514. PubMed ID: 37980664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study.
    Dahoun T; Calcia MA; Veronese M; Bloomfield P; Reis Marques T; Turkheimer F; Howes OD
    Brain Behav Immun; 2019 Aug; 80():742-750. PubMed ID: 31112791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.